WASHINGTON (dpa-AFX) - Below are the earnings highlights for Nektar Therapeutics (NKTR):
-Earnings: -$117.20 million in Q4 vs. -$112.16 million in the same period last year. -EPS: -$0.65 in Q4 vs. -$0.64 in the same period last year. -Analysts projected -$0.68 per share -Revenue: $23.46 million in Q4 vs. $33.86 million in the same period last year.
Copyright RTT News/dpa-AFX
NEKTAR THERAPEUTICS-Aktie komplett kostenlos handeln - auf Smartbroker.de